DPA International on MSN1h
AstraZeneca to buy Belgian cell therapy firm EsoBiotec for up to $1bnBritish drug major AstraZeneca said on Monday it has entered into a definitive agreement to acquire EsoBiotec, a ...
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback